In a study of invasive breast cancer (BC) patients with BRCA variants, the expression levels of five metastasis-specific proteins (CTSW, MRS2, SDCB2, RTN4 and RAD23B) were found to correlate with increased overall survival. This evidence concerns the gene CTSW and breast cancer.